Your browser doesn't support javascript.
loading
A Treatment-free Interval Allowed by Ponatinib as Fourth-line Therapy.
Bulla, Anna; Markovic, Uros; Bellofiore, Claudia; Stella, Stefania; Conticello, Concetta; DI Raimondo, Francesco; Stagno, Fabio.
Afiliación
  • Bulla A; Hematology Section and BMT Unit, Rodolico Hospital, AOU Policlinico "Rodolico - San Marco", Catania, Italy.
  • Markovic U; Hematology Section and BMT Unit, Rodolico Hospital, AOU Policlinico "Rodolico - San Marco", Catania, Italy.
  • Bellofiore C; Hematology Section and BMT Unit, Rodolico Hospital, AOU Policlinico "Rodolico - San Marco", Catania, Italy.
  • Stella S; Center of Experimental Oncology and Hematology, Department of Clinical and Experimental Medicine,AOU Policlinico "Rodolico - San Marco", Catania, Italy.
  • Conticello C; Hematology Section and BMT Unit, Rodolico Hospital, AOU Policlinico "Rodolico - San Marco", Catania, Italy.
  • DI Raimondo F; Hematology Section and BMT Unit, Rodolico Hospital, AOU Policlinico "Rodolico - San Marco", Catania, Italy.
  • Stagno F; Hematology Section and BMT Unit, Rodolico Hospital, AOU Policlinico "Rodolico - San Marco", Catania, Italy.
Cancer Diagn Progn ; 1(1): 19-22, 2021.
Article en En | MEDLINE | ID: mdl-35399694
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancer Diagn Progn Año: 2021 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancer Diagn Progn Año: 2021 Tipo del documento: Article País de afiliación: Italia